×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
Yahoo Finance
CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”),...
1 month ago
Tonix Pharmaceuticals Selects 2 CMOs To Support Tonmya In The U.S.
Contract Pharma
Tonix Pharmaceuticals Inc. Holding Corp., a biopharmaceutical company that has both marketed products and a pipeline of development candidates,...
1 month ago
StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)
Defense World
Read StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) at Defense World.
6 days ago
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
GlobeNewswire
CHATHAM, N.J., April 24, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company),...
2 weeks ago
One to Watch Companies - Infectious diseases, Tonix Pharmaceuticals
The Pharma Letter
BioNTech down as 3rd-qtr sales slump. 07-11-2022. Shares of Germany-based BioNTech were down 6.8% at $147.48 in pre-market New York...
5 days ago
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated - Tonix Pharmaceuticals (NASDAQ:TNXP)
Benzinga
Tonix Pharmaceuticals shares are trading lower by 22.3% Thursday afternoon. The company announced the pricing of a $4.4 million registered...
1 month ago
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Yahoo Finance
Positive results from confirmatory Phase 3 RESILIENT study reported in December 2023 position Tonmya™ for fibromyalgia for NDA submission...
1 month ago
Tonix Pharmaceuticals Announces Registered Direct Offering of up to $144 Million
Yahoo Finance
Led by healthcare-focused institutional investors. $30 million financing upfront with up to an additional $114 million tied to the exercise...
4 months ago
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of ...
GlobeNewswire
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome. March 25...
1 month ago
Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin ...
Yahoo Finance
Four Phase 2 investigator-initiated studies of TNX-1900 (intranasal potentiated oxytocin) are ongoing for pediatric obesity, binge eating...
1 month ago